Drug-induced alterations in morphology and level of cAMP in cultured human glioma cells.
D012368:4-(3-Butoxy-4-methoxybenzyl)-2-imidazolidinone / Q000494:pharmacology; D000225:Adenine / Q000031:analogs & derivatives; D002395:Catecholamines / Q000494:pharmacology*; D002460:Cell Line; D000242:Cyclic AMP / Q000378:metabolism*; D006152:Cyclic GMP / Q000031:analogs & derivatives; D004121:Dimethyl Sulfoxide / Q000494:pharmacology; D004837:Epinephrine / Q000494:pharmacology; D005910:Glioma; D007545:Isoproterenol / Q000494:pharmacology; D009474:Neurons / Q000187:drug effects* / Q000378:metabolism; D010208:Papaverine / Q000494:pharmacology; D010643:Phenoxybenzamine / Q000494:pharmacology; D011458:Prostaglandins E / Q000494:pharmacology*; D013015:Sotalol / Q000494:pharmacology; D015026:Zeatin / Q000494:pharmacology
D002395:Catecholamines; D011458:Prostaglandins E; D010643:Phenoxybenzamine; D012368:4-(3-Butoxy-4-methoxybenzyl)-2-imidazolidinone; D015026:Zeatin; D013015:Sotalol; D010208:Papaverine; D000242:Cyclic AMP; D006152:Cyclic GMP; D000225:Adenine; D007545:Isoproterenol; D004837:Epinephrine; D004121:Dimethyl Sulfoxide